The crucial role of PP2A tumor suppressor in NHL is confirmed by the promising results that FTY720 has shown in pre-clinical experiments in mantle cell lymphoma (MCL), an aggressive B-cell malignancy characterized by t(11;14) translocation and cyclin D1 expression (39, 63). The gene discussed is PTPA; the disease is non-Hodgkin lymphoma.